CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
about
Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application.Optimization of genome editing through CRISPR-Cas9 engineeringCRISPR-Cas9 technology and its application in haematological disorders.Progress towards generation of human haematopoietic stem cells.Platelet production from induced pluripotent stem cells.On the Way to Platelet Production
P2860
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
@ast
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
@en
type
label
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
@ast
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
@en
prefLabel
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
@ast
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
@en
P2093
P2860
P1433
P1476
CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes
@en
P2093
Chintan Jobaliya
Deborah L French
Huiying Zhi
Mortimer Poncz
Nanyan Zhang
Peter J Newman
Sridhar Rao
P2860
P304
P356
10.1182/BLOOD-2015-10-675751
P407
P50
P577
2015-12-03T00:00:00Z